Lumira Ventures logo

Lumira Ventures

North America, Ontario, Canada, Toronto

Description

Canada's leading health care & life sciences venture capital firm with a 30-year reputation building companies across North America.

Investor Profile

Lumira Ventures has made 77 investments, with 9 in the past 12 months and 27% as lead.

Stage Focus

  • Series A (29%)
  • Series B (22%)
  • Series C (16%)
  • Series D (13%)
  • Post Ipo Equity (6%)
  • Series E (6%)
  • Series Unknown (4%)
  • Seed (3%)
  • Convertible Note (1%)

Country Focus

  • United States (71%)
  • Canada (27%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Therapeutics
  • Medical
  • Biopharma
  • Pharmaceutical
  • Health Diagnostics
  • Developer Platform
  • Diabetes
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lumira Ventures frequently co-invest with?

Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 11
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 5
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 6
M. H. Carnegie & Co.
Oceania, Western Australia, Australia, Paddington
Co-Investments: 6
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 7
Amzak Health Investors
North America, New York, United States, New York
Co-Investments: 5
Aperture Venture Partners
North America, New York, United States, New York
Co-Investments: 6
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 5
Arboretum Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 6
Viva BioInnovator
Asia, Shanghai, China, Shanghai
Co-Investments: 6

Which angels does Lumira Ventures often collaborate with?

FM
North America, California, United States, Mountain View
Shared Deals: 1
RS
North America, California, United States, San Francisco
Shared Deals: 1
JM
North America, United States
Shared Deals: 1
BT
North America, Massachusetts, United States, Marblehead
Shared Deals: 1
PA
North America, Ontario, Canada
Shared Deals: 1
Clarissa Desjardins
North America, Quebec, Canada, Montréal
Shared Deals: 1

What are some of recent deals done by Lumira Ventures?

Cardiac Dimensions

Kirkland, Washington, United States

Cardiac Dimensions is a medical device company developing tools and techniques for the treatment of heart failure and related conditions.

BiotechnologyHealth CareMedical Device
Series EMar 20, 2025
Amount Raised: $53,000,000
Sound Blade Medical

Halifax, Nova Scotia, Canada

Sound Blade Medical is an early stage medical device startup which transforms healthcare by developing endoscopic, image-guided histotripsy.

Health CareMedicalMedical Device
Series AJan 29, 2025
Amount Raised: $16,500,000
XyloCor Therapeutics

King Of Prussia, Pennsylvania, United States

XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.

BiotechnologyHealth CarePharmaceutical
Series BJan 7, 2025
Amount Raised: $67,500,000
KisoJi Biotechnology

Laval-ouest, Quebec, Canada

KisoJi Biotechnology is a biotechnology company focused on healthcare and life sciences for research and development industries.

BiotechnologyLife ScienceMedicalTherapeutics
Series BDec 2, 2024
Amount Raised: $40,579,533
Axonis Therapeutics

Boston, Massachusetts, United States

Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.

BiotechnologyLife ScienceMedical
Series AOct 30, 2024
Amount Raised: $115,000,000
Alpha9 Theranostics

Vancouver, British Columbia, Canada

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

BiotechnologyMedicalProduct Research
Series COct 23, 2024
Amount Raised: $175,000,000
Spectrawave

Waltham, Massachusetts, United States

Spectrawave is a medical device company that develops optical diagnostic and therapeutic devices.

BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device
Series BSep 11, 2024
Amount Raised: $50,000,000
HistoSonics

Plymouth, Minnesota, United States

HistoSonics specializes in developing non-invasive medical devices, interventional radiology, and surgical robotics.

Health CareMedicalMedical Device
Series DAug 15, 2024
Amount Raised: $102,000,000
Endogenex

Plymouth, Minnesota, United States

Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.

Health CareMedical DeviceTherapeutics
Series CJun 25, 2024
Amount Raised: $88,000,000
enGene

Vancouver, British Columbia, Canada

enGene is a biotechnology company develops treatment for mucosal diseases through inducing therapeutic proteins of harmful proteins.

BiotechnologyDiabetesGeneticsHealth Care
Post Ipo EquityFeb 14, 2024
Amount Raised: $200,000,000